Statistics for Pulse Biosciences (id:5459 PLSE)
Valuation metrics
Market cap
1.12B
Enterprise value
1.02B
Trailing P/E (ttm)
-20.78
Forward P/E
-20.30
PEG ratio
-20.30
Price/Sales (ttm)
Price/Book (mrq)
14.21
Enterprise Value/Revenue
Enterprise Value/EBITDA
-21.63
Overview
Shares outstanding
61.52M
Float
17.23M
Shares short
2.12M
% Held by insiders
3.00%
% Held by institutions
5.00%
Average volume (10 days)
195.99K
Average volume (90 days)
Price summary
52-Week low
6.60
52-Week high
22.69
52-Week change
29.81%
Beta
1.75
50-Day moving average
17.80
200-Day moving average
14.20
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-38.15%
Return on equity
-70.28%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-47,334,000.00
Net income to common (ttm)
-46,133,000.00
Diluted EPS (ttm)
3.00
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
79.03M
Total cash per share (mrq)
1.28
Total debt (mrq)
8.37M
Total Debt/Equity (mrq)
10.57
Current ratio (mrq)
1.19K%
Book value per share (mrq)
1.29
Cash flow
Cash flow statement
-33,981,000.00
Levered free cash flow (LFCF)
-18,813,124.00